99 related articles for article (PubMed ID: 2977786)
21. Mechanisms of photoreceptor cell death in cancer-associated retinopathy.
Maeda T; Maeda A; Maruyama I; Ogawa KI; Kuroki Y; Sahara H; Sato N; Ohguro H
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):705-12. PubMed ID: 11222531
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of the carbohydrate antigen CA-50 in pancreatic disease.
Blind PJ; Dahlgren ST
Acta Chir Scand; 1987 Jan; 153(1):45-9. PubMed ID: 3472420
[TBL] [Abstract][Full Text] [Related]
23. Differential diagnosis of pancreatic cancer and chronic pancreatitis by a monoclonal antibody detecting a new cancer-associated antigen (CA 19-9).
Malesci A; Tommasini MA; Bocchia P; Zerbi A; Beretta E; Vecchi M; Di Carlo V
Ric Clin Lab; 1984; 14(3):303-6. PubMed ID: 6522955
[No Abstract] [Full Text] [Related]
24. Comparison of two newly identified tumor markers (CAR-3 and DU-PAN-2) with CA 19-9 in patients with pancreatic cancer.
Ferrara C; Basso D; Fabris C; Malesci A; Fogar P; Meggiato T; Panozzo MP; Scalon P; Del Favero G; Plebani M
Tumori; 1991 Feb; 77(1):56-60. PubMed ID: 1673269
[TBL] [Abstract][Full Text] [Related]
25. [Carcinoma-associated retinopathy: a review with clinical examples].
Sobottka B; Schlote T; Besch D; Djelebova T; Wilhelm H; Zrenner E
Klin Monbl Augenheilkd; 2000 Jan; 216(1):17-24. PubMed ID: 10702938
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic juice 90K and serum CA 19-9 combined determination can discriminate between pancreatic cancer and chronic pancreatitis.
Gentiloni N; Caradonna P; Costamagna G; D'Ostilio N; Perri V; Mutignani M; Febbraro S; Tinari N; Iacobelli S; Natoli C
Am J Gastroenterol; 1995 Jul; 90(7):1069-72. PubMed ID: 7611198
[TBL] [Abstract][Full Text] [Related]
27. [Paraneoplastic retinopathy and anti-recoverin antibodies].
Bataller L; Graus F; Dalmau J
Neurologia; 2002 Mar; 17(3):156. PubMed ID: 11927105
[No Abstract] [Full Text] [Related]
28. Sandwich radioimmunometric assay with murine monoclonal antibody, NCC-ST-439, for serological diagnosis of human cancers.
Sugano K; Ohkura H; Maruyama T; Watanabe M; Hirohashi S; Shimosato Y; Kodaira S; Abe O
Jpn J Cancer Res; 1988 May; 79(5):618-25. PubMed ID: 3136114
[TBL] [Abstract][Full Text] [Related]
29. Laboratory tests in the diagnosis of the chronic pancreatic diseases. Part 6. Differentiation between chronic pancreatitis and pancreatic cancer.
Boyd EJ; Rinderknecht H; Wormsley KG
Int J Pancreatol; 1988 May; 3(4):229-40. PubMed ID: 3290345
[No Abstract] [Full Text] [Related]
30. Serum antibodies to retinal antigens in lung cancer and sarcoidosis.
Jankowska R; Witkowska D; Porebska I; Kuropatwa M; Kurowska E; Gorczyca WA
Pathobiology; 2004; 71(6):323-8. PubMed ID: 15627843
[TBL] [Abstract][Full Text] [Related]
31. Unique retina cell phenotypes revealed by immunological analysis of recoverin expression in rat retina cells.
McGinnis JF; Stepanik PL; Chen W; Elias R; Cao W; Lerious V
J Neurosci Res; 1999 Jan; 55(2):252-60. PubMed ID: 9972828
[TBL] [Abstract][Full Text] [Related]
32. Multiparametric tumor marker (CA 19-9, CEA, AFP, POA) analyses of pancreatic juices and sera in pancreatic diseases.
Schmiegel WH; Eberl W; Kreiker C; Kalthoff H; Bützow GH; Jessen K; Klapdor R; Soehendra N; Wargenau M; Classen M
Hepatogastroenterology; 1985 Jun; 32(3):141-5. PubMed ID: 2410346
[TBL] [Abstract][Full Text] [Related]
33. CAR-3, a monoclonal antibody-defined antigen expressed on human carcinomas.
Prat M; Morra I; Bussolati G; Comoglio PM
Cancer Res; 1985 Nov; 45(11 Pt 2):5799-807. PubMed ID: 2413998
[TBL] [Abstract][Full Text] [Related]
34. Comparison of two sialosyl-Tn binding monoclonal antibodies (MLS102 and B72.3) in detecting pancreatic cancer.
Ching CK; Holmes SW; Holmes GK; Long RG
Gut; 1993 Dec; 34(12):1722-5. PubMed ID: 8282261
[TBL] [Abstract][Full Text] [Related]
35. Anti-recoverin antibodies cause the apoptotic death of mammalian photoreceptor cells in vitro.
Chen W; Elias RV; Cao W; Lerious V; McGinnis JF
J Neurosci Res; 1999 Sep; 57(5):706-18. PubMed ID: 10462694
[TBL] [Abstract][Full Text] [Related]
36. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.
Ohguro H; Ogawa K; Maeda T; Maeda A; Maruyama I
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3160-7. PubMed ID: 10586938
[TBL] [Abstract][Full Text] [Related]
37. CAM 17.1--a new diagnostic marker in pancreatic cancer.
Gansauge F; Gansauge S; Parker N; Beger MI; Poch B; Link KH; Safi F; Beger HG
Br J Cancer; 1996 Dec; 74(12):1997-2002. PubMed ID: 8980403
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a small-cell-lung-carcinoma cell line from a patient with cancer-associated retinopathy.
Yamaji Y; Matsubara S; Yamadori I; Sato M; Fujita T; Fujita J; Takahara J
Int J Cancer; 1996 Mar; 65(5):671-6. PubMed ID: 8598320
[TBL] [Abstract][Full Text] [Related]
39. CA 19-9 assay in differential diagnosis of pancreatic carcinoma from inflammatory pancreatic diseases.
Piantino P; Andriulli A; Gindro T; Pecchio F; Masoero G; Cavallini G; Naccarato R; Dobrilla G
Am J Gastroenterol; 1986 Jun; 81(6):436-9. PubMed ID: 3458359
[TBL] [Abstract][Full Text] [Related]
40. Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' sera.
Dietel M; Arps H; Klapdor R; Müller-Hagen S; Sieck M; Hoffmann L
J Cancer Res Clin Oncol; 1986; 111(3):257-65. PubMed ID: 3460995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
